Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Verhoef

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Gynecologic Oncology|August 12, 2014
Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancerViola M J Verhoef, Daniëlle A M Heideman, Folkert J van Kemenade, et al.
International Journal of Cancer|June 14, 2014
Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screeningRemko P Bosgraaf, Viola M J Verhoef, Leon F A G Massuger, et al.
Gynecologic Oncology|February 11, 2015
Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapesViola M J Verhoef, Folkert J van Kemenade, Lawrence Rozendaal, et al.
The Lancet. Oncology|February 18, 2014
Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trialViola M J Verhoef, Remko P Bosgraaf, Folkert J van Kemenade, et al.
International Journal of Cancer|March 19, 2016
The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samplesRenée M F Ebisch, Gabriëlle M de Kuyper-de Ridder, Remko P Bosgraaf, et al.
Gynecologic Oncology|February 28, 2016
Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive womenLise M A De Strooper, Viola M J Verhoef, Johannes Berkhof, et al.
The Lancet. Oncology|November 12, 2023
Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort studyTeska N Schuurman, Mirte Schaafsma, Kaylee H To, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 26, 2025
Improving pre-operative binary grading: relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinomaPuk Meijs-Hermanns, Henrica M J Werner, Loes Kooreman, et al.
Science Translational Medicine|September 20, 2019
Antimalarial pantothenamide metabolites target acetyl-coenzyme A biosynthesis in <i>Plasmodium falciparum</i>Joost Schalkwijk, Erik L Allman, Patrick A M Jansen, et al.
Nature Communications|April 21, 2022
Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183Laura E de Vries, Patrick A M Jansen, Catalina Barcelo, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Gynecologic Oncology|August 12, 2014
Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancerViola M J Verhoef, Daniëlle A M Heideman, Folkert J van Kemenade, et al.
International Journal of Cancer|June 14, 2014
Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screeningRemko P Bosgraaf, Viola M J Verhoef, Leon F A G Massuger, et al.
Gynecologic Oncology|February 11, 2015
Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapesViola M J Verhoef, Folkert J van Kemenade, Lawrence Rozendaal, et al.
The Lancet. Oncology|February 18, 2014
Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trialViola M J Verhoef, Remko P Bosgraaf, Folkert J van Kemenade, et al.
International Journal of Cancer|March 19, 2016
The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samplesRenée M F Ebisch, Gabriëlle M de Kuyper-de Ridder, Remko P Bosgraaf, et al.
Gynecologic Oncology|February 28, 2016
Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive womenLise M A De Strooper, Viola M J Verhoef, Johannes Berkhof, et al.
The Lancet. Oncology|November 12, 2023
Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort studyTeska N Schuurman, Mirte Schaafsma, Kaylee H To, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 26, 2025
Improving pre-operative binary grading: relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinomaPuk Meijs-Hermanns, Henrica M J Werner, Loes Kooreman, et al.
Science Translational Medicine|September 20, 2019
Antimalarial pantothenamide metabolites target acetyl-coenzyme A biosynthesis in <i>Plasmodium falciparum</i>Joost Schalkwijk, Erik L Allman, Patrick A M Jansen, et al.
Nature Communications|April 21, 2022
Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183Laura E de Vries, Patrick A M Jansen, Catalina Barcelo, et al.
Pageof 9